Anne-Céline Reyss

660 total citations
10 papers, 479 citations indexed

About

Anne-Céline Reyss is a scholar working on Public Health, Environmental and Occupational Health, Reproductive Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Anne-Céline Reyss has authored 10 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 7 papers in Reproductive Medicine and 2 papers in Obstetrics and Gynecology. Recurrent topics in Anne-Céline Reyss's work include Reproductive Biology and Fertility (9 papers), Ovarian function and disorders (7 papers) and Ovarian cancer diagnosis and treatment (5 papers). Anne-Céline Reyss is often cited by papers focused on Reproductive Biology and Fertility (9 papers), Ovarian function and disorders (7 papers) and Ovarian cancer diagnosis and treatment (5 papers). Anne-Céline Reyss collaborates with scholars based in France and Finland. Anne-Céline Reyss's co-authors include Didier Dewailly, Sophie Catteau-Jonard, Pascal Pigny, Maryse Leroy, E. Poncelet, Nathalie Bourcigaux, Olli Ritvos, Frédérique Kuttenn, Paul Laissue and Philippe Touraine and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Human Reproduction and European Journal of Endocrinology.

In The Last Decade

Anne-Céline Reyss

9 papers receiving 463 citations

Peers

Anne-Céline Reyss
Lucrecia Calvo Argentina
Timothée Fraisse Switzerland
Yong‐Seog Park South Korea
Ryan Sisk United States
Matthew Dapas United States
Lucrecia Calvo Argentina
Anne-Céline Reyss
Citations per year, relative to Anne-Céline Reyss Anne-Céline Reyss (= 1×) peers Lucrecia Calvo

Countries citing papers authored by Anne-Céline Reyss

Since Specialization
Citations

This map shows the geographic impact of Anne-Céline Reyss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne-Céline Reyss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne-Céline Reyss more than expected).

Fields of papers citing papers by Anne-Céline Reyss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne-Céline Reyss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne-Céline Reyss. The network helps show where Anne-Céline Reyss may publish in the future.

Co-authorship network of co-authors of Anne-Céline Reyss

This figure shows the co-authorship network connecting the top 25 collaborators of Anne-Céline Reyss. A scholar is included among the top collaborators of Anne-Céline Reyss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne-Céline Reyss. Anne-Céline Reyss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Catteau-Jonard, Sophie, Pascal Pigny, Anne-Céline Reyss, et al.. (2008). Changes in Serum Anti-Müllerian Hormone Level During Low-Dose Recombinant Follicular-Stimulating Hormone Therapy for Anovulation in Polycystic Ovary Syndrome. Obstetrical & Gynecological Survey. 63(4). 230–231. 1 indexed citations
2.
Catteau-Jonard, Sophie, et al.. (2007). Delayed puberty with extreme uterine hypotrophy: do not conclude too early to the absence of the uterus. 14. 1 indexed citations
3.
Catteau-Jonard, Sophie, Pascal Pigny, Anne-Céline Reyss, et al.. (2007). Changes in Serum Anti-Mullerian Hormone Level during Low-Dose Recombinant Follicular-Stimulating Hormone Therapy for Anovulation in Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 92(11). 4138–4143. 63 indexed citations
4.
Dewailly, Didier, et al.. (2007). The excess in 2–5 mm follicles seen at ovarian ultrasonography is tightly associated to the follicular arrest of the polycystic ovary syndrome. Human Reproduction. 22(6). 1562–1566. 41 indexed citations
5.
Reyss, Anne-Céline & Sophie Christin-Maître. (2006). Les gènes et l’insuffisance ovarienne prématurée. 8(3). 225–231.
6.
Jonard, S., et al.. (2006). Retard pubertaire avec hypotrophie utérine majeure: ne pas conclure trop vite à l'absence d'utérus. Gynécologie Obstétrique & Fertilité. 34(11). 1029–1035. 5 indexed citations
7.
Laissue, Paul, Sophie Christin‐Maître, Philippe Touraine, et al.. (2006). Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure. European Journal of Endocrinology. 154(5). 739–744. 206 indexed citations
8.
Reyss, Anne-Céline, et al.. (2006). Le consensus de Rotterdam appliqué à l'adolescente : quels examens prescrire et comment les interpréter pour établir le diagnostic de SOPK ?. Gynécologie Obstétrique & Fertilité. 34(4). 341–346. 10 indexed citations
9.
Dewailly, Didier, Sophie Catteau-Jonard, Anne-Céline Reyss, Maryse Leroy, & Pascal Pigny. (2006). Oligoanovulation with Polycystic Ovaries But Not Overt Hyperandrogenism. The Journal of Clinical Endocrinology & Metabolism. 91(10). 3922–3927. 146 indexed citations
10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026